Oral Novo Nordisk diabetes drug poses no more heart risk than placebo: study
By Gene Emery (Reuters) – An experimental oral form of a Novo Nordisk drug for type 2...
Read MoreJun 11, 2019
By Gene Emery (Reuters) – An experimental oral form of a Novo Nordisk drug for type 2...
Read MoreJun 11, 2019
By Linda Carroll (Reuters Health) – Military women who are sexually assaulted may be at an especially high risk of developing lasting sexual pain, a U.S. study suggests. Researchers who interviewed more than 1,000 female...
Read MoreJun 11, 2019
By Carolyn Crist (Reuters Health) – Using consistent bedtime strategies such as allowing infants to fall asleep on their own can improve their sleep, New Zealand researchers say. Children whose parents used these...
Read MoreJun 11, 2019
By Stephanie Nebehay and Elias Biryabarema GENEVA/KAMPALA (Reuters) – Uganda has confirmed its first case of Ebola during the current outbreak, a 5-year-old Congolese child who is receiving care after arriving from the...
Read MoreJun 11, 2019
By Lisa Rapaport (Reuters Health) – Healthy people at risk for HIV should take a daily pill to minimize their chances of getting the virus, according to new guidelines from an influential panel of U.S. physicians. Anyone...
Read MoreJun 11, 2019
By Saumya Joseph (Reuters Health) – Too little sleep – or too much – can be tied to problems with blood sugar levels, not just in people with diabetes but also in people at high risk for developing the disease,...
Read MoreJun 11, 2019
(Reuters) – The U.S. Food and Drug Administration on Tuesday carved out new recommendations...
Read MoreJun 11, 2019
By Eissa al-Rajehy HAJJAH, Yemen (Reuters) – In the last two weeks Dr Asmahan Ahmed has seen...
Read MoreJun 11, 2019
TEL AVIV (Reuters) – Israel’s Aidoc, which provides artificial intelligence tools for radiologists, said on Tuesday the U.S. Food and Drug Administration cleared its product for triage of cervical spine fractures. The...
Read MoreJun 11, 2019
(Reuters) – Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer. The drug was approved for use as a...
Read MoreJun 10, 2019
By Brendan O’Brien (Reuters) – The only abortion clinic in Missouri can stay open...
Read MoreJun 10, 2019
By Manas Mishra (Reuters Health) – While many people can pick up on signs of postpartum...
Read MoreJun 10, 2019
By Lisa Rapaport (Reuters Health) – Legalizing medical marijuana no longer appears to be linked with a drop in fatal opioid overdoses, according to a new U.S. study that calls into question the potential for cannabis to...
Read MoreJun 10, 2019
By Saumya Joseph (Reuters) – (The June 8 story corrects first paragraph to clarify that the study compared patients with type 2 diabetes before and after using Abbott’s device; In paragraph 4, clarifies that the...
Read MoreJun 10, 2019
By Lisa Rapaport (Reuters Health) – Compared to smaller facilities, hospitals that provide complex care for critical illness or serious injury may find it harder to make patients happy, a U.S. study suggests. Patients may...
Read MoreJun 10, 2019
By Lisa Rapaport (Reuters Health) – For middle-aged and older women, sleeping with the television or lights on has been linked with higher odds of becoming obese, in a recent U.S. study. While a high-calorie diet and...
Read MoreJun 10, 2019
(Reuters) – The United States’ worst measles outbreak in a quarter-century spread to...
Read MoreJun 10, 2019
SHANGHAI (Reuters) – China said on Monday it will tighten regulations on human genetic...
Read MoreJun 9, 2019
By Gene Emery (Reuters Health) – In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a...
Read MoreJun 7, 2019
By Julie Ingwersen CHICAGO (Reuters) – The U.S. Department of Agriculture has confirmed the discovery of unapproved, genetically modified (GM) wheat plants growing in an un-planted agricultural field in Washington state....
Read More